Daily Financial Update Good morning—October 22, 2025. Markets shrugged off the week’s drama...
Author - Franklin Jay
“SMMT’s Phase 3 Trial Expansion: Don’t Miss This...
Company Overview and Phase 3 Expansion Summit Therapeutics Inc. (NASDAQ: SMMT) is a clinical-stage...
Avoid the Hype: CXMT IPO and ECB Warnings
Opening Recap Market Pulse: Chip IPO chatter from CXMT edges market sentiment into cautious...
“SVRA: Class Action Filed—Is Your Investment at Risk...
Class Action Background Savara Inc. (NASDAQ: SVRA) – a clinical-stage biotech focused on rare...
Ditch AI Hype, Eye Midcap Value Plays Now
Opening Recap Market Pulse: Equities rallied modestly as bargain hunters targeted beaten-down tech...
LIVE: Blazpay’s Crypto Presale Sparks TRON &...
Introduction The crypto world may be buzzing about Blazpay’s AI-driven token presale and its...
Megacap Surge and FPI Returns Fuel Market Rally
Opening Recap Market Pulse: Indian equities edge up after foreign portfolio investors poured ₹6,480...
TEVA’s FDA Win: New Treatment for Bipolar I Disorder!
Overview – A New Bipolar I Treatment Boosts Teva’s Prospects Teva Pharmaceutical Industries (NYSE:...
Late Cycle Industrials Shine as Energy Lags
Opening Briefing Market Pulse: Yesterday’s action was a tightrope—industrials and property names...
CYTK: Major Inducement Grants Could Drive Share Surge!
Introduction Cytokinetics (NASDAQ: CYTK) is a clinical-stage biopharmaceutical company specializing...